Related Experiment Videos
Muscarinic receptor subtype (M1) identification on rabbit pulmonary vascular endothelium in vivo
1Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta.
Abstract:
We have investigated the presence of M1-subtype muscarinic receptors on pulmonary vascular endothelium in vivo. Utilizing multiple indicator-dilution techniques, we studied [3H]-pirenzepine ([3H]-PNZ; a selective M1 receptor antagonist) binding during a single transpulmonary pass in anesthetized, artificially ventilated rabbits, before and after administration of 4.3 mumol/kg of the nonselective muscarinic receptor antagonist atropine. [14C]-Dextran (MW = 70,000-90,000) served as the intravascular indicator. Before atropine administration, approximately 20% of [3H]-PNZ was lost (i.e., presumed bound to PNZ-specific and nonspecific sites) during a single pass through the pulmonary microvasculature. A significant decrease in [3H]-PNZ binding occurred 90 min after atropine (to approximately 60% of total initial binding), but not after saline, reflecting the loss of specific binding to M1 receptors. These data are in support of previous findings from our laboratory indicating a pressor response to M1 receptor stimulation in the rabbit pulmonary circulation as well as an endothelium-dependent contractile response to M1 receptor stimulation in vitro.
Insights
Researchers found M1 muscarinic receptors on pulmonary vascular endothelium in rabbits. Blocking these receptors with atropine significantly reduced [3H]-pirenzepine binding, confirming their presence and role in pulmonary circulation.
Area of Science:
- Cardiovascular Research
- Pulmonary Circulation Physiology
- Pharmacology
Background:
- Muscarinic receptors play roles in various physiological processes.
- M1-subtype muscarinic receptors have been implicated in cardiovascular regulation.
- Their presence and function on pulmonary vascular endothelium require further investigation.
Purpose of the Study:
- To investigate the presence and binding characteristics of M1-subtype muscarinic receptors on pulmonary vascular endothelium in vivo.
- To confirm the specific binding of [3H]-pirenzepine to M1 receptors in the pulmonary vasculature.
- To support previous findings on M1 receptor stimulation in the rabbit pulmonary circulation.
Main Methods:
- Utilized multiple indicator-dilution techniques in anesthetized, artificially ventilated rabbits.
- Measured the transpulmonary passage and binding of [3H]-pirenzepine, a selective M1 receptor antagonist.
- Administered atropine (nonselective muscarinic antagonist) and saline as controls, with [14C]-Dextran as an intravascular indicator.
Main Results:
- Approximately 20% of [3H]-pirenzepine was lost during a single transpulmonary pass, indicating binding to pulmonary vascular sites.
- A significant decrease in [3H]-pirenzepine binding (to ~60% of initial) was observed 90 minutes after atropine administration.
- Saline administration did not affect [3H]-pirenzepine binding, confirming the specificity of atropine's effect on M1 receptors.
Conclusions:
- These findings provide in vivo evidence for the presence of M1-subtype muscarinic receptors on rabbit pulmonary vascular endothelium.
- The results support the role of these receptors in mediating pressor and contractile responses within the pulmonary circulation.
- This study enhances understanding of M1 receptor pharmacology in the pulmonary vasculature.